86 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
– Assessment days (shown only for Cohort 1 above) is repeated for each cohort per eye; intensity & contrast assessment, kinetic perimetry, functional … only, N = number of patients reporting event, n (%) = % of patients reporting event
17 Kinetic Visual Field (Goldmann Perimetry) Assessment & Insights
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
per eye § Cohort 1 – NLP/BLP patients; Cohort 2 – HM/CF patients § Primary – AEs, PK & labs § Secondary – Assessment days (shown only for Cohort 1 above … ) is repeated for each cohort per eye; intensity & contrast assessment, kine8c perimetry, func8onal MRI, etc. § Safety review conducted
8-K
EX-99.1
axa41f5q9z7eb
9 Nov 23
Results of Operations and Financial Condition
7:01am
424B1
qqh0 c4limglmtch
2 Jun 23
Prospectus with pricing info
5:08pm
FWP
xzta8z40
15 May 23
Free writing prospectus
5:18pm
8-K
EX-99.1
tux8afb
27 Apr 23
Other Events
2:55pm
8-K
coruig728a6
30 Mar 23
Changes in Registrant's Certifying Accountant
7:02am
424B3
x2trm7t2xxj66ccmmegq
28 Dec 22
Prospectus supplement
4:48pm